dc.contributor.author | Melby, Katrine | |
dc.contributor.author | Fasmer, Ole Bernt | |
dc.contributor.author | Henriksen, Tone Elise Gjøtterud | |
dc.contributor.author | Gråwe, Rolf W. | |
dc.contributor.author | Aamo, Trond Oskar | |
dc.contributor.author | Spigset, Olav | |
dc.date.accessioned | 2021-06-24T08:51:05Z | |
dc.date.available | 2021-06-24T08:51:05Z | |
dc.date.created | 2020-12-04T08:28:04Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://hdl.handle.net/11250/2761046 | |
dc.description.abstract | Background and aims
The alcohol withdrawal syndrome increases autonomic activation and stress in patients during detoxification, leading to alterations in motor activity and sleep irregularities. Intranasal oxytocin has been proposed as a possible treatment of acute alcohol withdrawal. The aim of the present study was to explore whether actigraphy could be used as a tool to register symptoms during alcohol detoxification, whether oxytocin affected actigraphy variables related to motor activity and sleep compared to placebo during detoxification, and whether actigraphy-recorded motor function during detoxification was different from that in healthy controls.
Methods
This study was a part of a randomized, double blind, placebo-controlled trial in which 40 patients with alcohol use disorder admitted for acute detoxification were included. Of these, 20 received insufflations with intranasal oxytocin and 20 received placebo. Outcomes were actigraphy-recorded motor activity during 5-hour sequences following the insufflations and a full 24-hour period, as well as actigraphy-recorded sleep. Results were related to clinical variables of alcohol intake and withdrawal, including self-reported sleep. Finally, the actigraphy results were compared to those in a group of 34 healthy individuals.
Results
There were no significant differences between the oxytocin group and the placebo group for any of actigraphy variables registered. Neither were there any correlations between actigraphy-recorded motor function and clinical symptoms of alcohol withdrawal, but there was a significant association between self-reported and actigraphy-recorded sleep. Compared to healthy controls, motor activity during alcohol withdrawal was lower in the evenings and showed increased variability.
Conclusion
Intranasal oxytocin did not affect actigraphy-recorded motor activity nor sleep in patients with acute alcohol withdrawal. There were no findings indicating that actigraphy can be used to evaluate the degree of withdrawal symptoms during detoxification. However, patients undergoing acute alcohol withdrawal had a motor activity pattern different from than in healthy controls. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | PLOS | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Actigraphy assessment of motor activity and sleep in patients with alcohol withdrawal syndrome and the effects of intranasal oxytocin | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2020 The Authors | en_US |
dc.source.articlenumber | e0228700 | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | https://doi.org/10.1371/journal.pone.0228700 | |
dc.identifier.cristin | 1856082 | |
dc.source.journal | PLOS ONE | en_US |
dc.source.40 | 13 | |
dc.source.14 | 15 | |
dc.identifier.citation | PLOS ONE. 2020, 15(2): e0228700 | en_US |
dc.source.volume | 15 | en_US |
dc.source.issue | 2 | en_US |